I am still a bit bemused by the wording of the announcement.
”FDA has informed the company that following additional consideration the available clinical data from its Phase 3 study MSB-GVHD001 appears sufficient to support submission”
Note - not “data”, not “new information”, but “consideration”.
Were the FDA head honchos having a round of golf, and decided amongst themselves that they had been a bit hard on the Aussie battler? Then back to the clubhouse for a scotch or three.
Or perhaps Big Pharma have “advised” the FDA top order that Meso's gonads have been squeezed enough, so give them a win that also allows BP to make a cheap TO?
Don't get me wrong. My wife is very happy to see the reverse in fortunes, and so quick after that dilutive capital raise too!
- Forums
- ASX - By Stock
- MSB
- Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-451
-
-
- There are more pages in this discussion • 646 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.005(0.50%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.00 | $1.01 | 94.0¢ | $8.450M | 8.665M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
15 | 183505 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.01 | 34555 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
14 | 178505 | 1.005 |
17 | 336128 | 1.000 |
12 | 99794 | 0.995 |
7 | 87436 | 0.990 |
3 | 118866 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.010 | 26380 | 11 |
1.015 | 106830 | 13 |
1.020 | 290595 | 15 |
1.025 | 181622 | 7 |
1.030 | 25000 | 1 |
Last trade - 13.50pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online